Aimee Doran - Concepedia

Author

Aimee Doran

University of Colorado Denver

Also Known As

A. Doran, A. K. Doran, Aimee Doran, Aimee K. Doran

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver Children's Hospital Colorado United Therapeutics (United States)Triangle Columbia University

About

Aimee Doran is an author at University of Colorado Denver specializing in medicine, pulmonary vascular disease, and hypertension.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.2K
2	Public Health	8	8	890
3	Emergency Medicine	2	2	177
4	Nephrology	1	1	77
5	Pharmacology	1	1	82

Aimee Doran

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Perioperative Complications in Children with Pulmonary Hypertension Undergoing Noncardiac Surgery or Cardiac Catheterization M. J. Carmosino, Robert H. Friesen, Aimee Doran, Anesthesia & Analgesia	2007	322
Effects of Long-Term Bosentan in Children With Pulmonary Arterial Hypertension Erika B. Rosenzweig, D. Dunbar Ivy, Allison Widlitz, Journal of the American College of Cardiology HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseasePediatric Heart Disease	2005	261
Short- and Long-Term Effects of Inhaled Iloprost Therapy in Children With Pulmonary Arterial Hypertension D. Dunbar Ivy, Aimee Doran, K Smith, Journal of the American College of Cardiology AsthmaHypertensionPulmonary Arterial HypertensionLong-term EffectsPediatrics	2008	200
Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension Aimee Doran, D. Dunbar Ivy, Robyn J. Barst, International Journal of Clinical Practice Central Venous CatheterIntravenous ProstanoidsPharmacotherapyThrombosisVenous Thrombosis	2008	119
Brain Natriuretic Peptide Levels in Managing Pediatric Patients With Pulmonary Arterial Hypertension Anna Bernus, Brandie D. Wagner, Frank J. Accurso, CHEST Journal HypertensionPulmonary Arterial HypertensionPulmonary CirculationManaging Pediatric PatientsCardiovascular Disease	2008	109
Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension - Seven sites, United States, 2003-2006 Robyn J. Barst, Erika B. Rosenzweig, Evelyn M. Horn, Pulmonary Arterial HypertensionAntibioticsHealthcare-associated InfectionBloodstream InfectionsClinical Infection	2007	94
Transition of Stable Pediatric Patients With Pulmonary Arterial Hypertension from Intravenous Epoprostenol to Intravenous Treprostinil D. Dunbar Ivy, Lori Claussen, Aimee Doran The American Journal of Cardiology Stable Pediatric PatientsHypertensionPulmonary Arterial HypertensionPulmonary CirculationPediatrics	2007	82
Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan D. Dunbar Ivy, Aimee Doran, Lori Claussen, The American Journal of Cardiology HypertensionPulmonary Arterial HypertensionMedicineAntihypertensive TherapyCardiovascular Pharmacology	2004	82
Portopulmonary Hypertension in Pediatric Patients Adria A. Condino, D. Dunbar Ivy, Judith A. O’Connor, The Journal of Pediatrics HypertensionPortopulmonary HypertensionCardiovascular DiseasePediatric Heart DiseasePediatrics	2005	77
Closed-Hub Systems with Protected Connections and the Reduction of Risk of Catheter-Related Bloodstream Infection in Pediatric Patients Receiving Intravenous Prostanoid Therapy for Pulmonary Hypertension D. Dunbar Ivy, Michelle Calderbank, Brandie D. Wagner, Infection Control and Hospital Epidemiology	2009	75

Page 1